These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23516588)

  • 1. Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.
    Amran MY; Fujii J; Suzuki SO; Kolling GL; Villanueva SY; Kainuma M; Kobayashi H; Kameyama H; Yoshida S
    PLoS One; 2013; 8(3):e58959. PubMed ID: 23516588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice.
    Amran MY; Fujii J; Kolling GL; Villanueva SY; Kainuma M; Kobayashi H; Kameyama H; Yoshida S
    Microb Pathog; 2013 Dec; 65():57-62. PubMed ID: 24120399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli O104:H4 Pathogenesis: an Enteroaggregative E. coli/Shiga Toxin-Producing E. coli Explosive Cocktail of High Virulence.
    Navarro-Garcia F
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK
    JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.
    Zangari T; Melton-Celsa AR; Panda A; Boisen N; Smith MA; Tatarov I; De Tolla LJ; Nataro JP; O'Brien AD
    Infect Immun; 2013 May; 81(5):1562-74. PubMed ID: 23439303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.
    Jandhyala DM; Vanguri V; Boll EJ; Lai Y; McCormick BA; Leong JM
    Infect Dis Clin North Am; 2013 Sep; 27(3):631-49. PubMed ID: 24011834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the Shiga-toxin-producing enteroaggregative Escherichia coli O104:H4 German outbreak strain and of STEC strains isolated in Spain.
    Mora A; Herrrera A; López C; Dahbi G; Mamani R; Pita JM; Alonso MP; Llovo J; Bernárdez MI; Blanco JE; Blanco M; Blanco J
    Int Microbiol; 2011 Sep; 14(3):121-41. PubMed ID: 22101411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.
    Bielaszewska M; Mellmann A; Zhang W; Köck R; Fruth A; Bauwens A; Peters G; Karch H
    Lancet Infect Dis; 2011 Sep; 11(9):671-6. PubMed ID: 21703928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.
    Muniesa M; Hammerl JA; Hertwig S; Appel B; Brüssow H
    Appl Environ Microbiol; 2012 Jun; 78(12):4065-73. PubMed ID: 22504816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
    McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
    N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.
    Rasko DA; Webster DR; Sahl JW; Bashir A; Boisen N; Scheutz F; Paxinos EE; Sebra R; Chin CS; Iliopoulos D; Klammer A; Peluso P; Lee L; Kislyuk AO; Bullard J; Kasarskis A; Wang S; Eid J; Rank D; Redman JC; Steyert SR; Frimodt-Møller J; Struve C; Petersen AM; Krogfelt KA; Nataro JP; Schadt EE; Waldor MK
    N Engl J Med; 2011 Aug; 365(8):709-17. PubMed ID: 21793740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.
    Magnus T; Röther J; Simova O; Meier-Cillien M; Repenthin J; Möller F; Gbadamosi J; Panzer U; Wengenroth M; Hagel C; Kluge S; Stahl RK; Wegscheider K; Urban P; Eckert B; Glatzel M; Fiehler J; Gerloff C
    Brain; 2012 Jun; 135(Pt 6):1850-9. PubMed ID: 22539260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin-producing Escherichia coli strains from cattle as a source of the Stx2a bacteriophages present in enteroaggregative Escherichia coli O104:H4 strains.
    Beutin L; Hammerl JA; Reetz J; Strauch E
    Int J Med Microbiol; 2013 Dec; 303(8):595-602. PubMed ID: 24012149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli.
    Ramstad SN; Taxt AM; Naseer U; Wasteson Y; Bjørnholt JV; Brandal LT
    Microb Pathog; 2021 Mar; 152():104636. PubMed ID: 33242644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic analysis of two novel sporadic Shiga toxin-producing Escherichia coli O104:H4 strains isolated 2011 in Germany.
    Tietze E; Dabrowski PW; Prager R; Radonic A; Fruth A; Auraß P; Nitsche A; Mielke M; Flieger A
    PLoS One; 2015; 10(4):e0122074. PubMed ID: 25836671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
    Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
    Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
    Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.